Effects of dietary Bacillus amyloliquefaciens supplementation on growth performance, intestinal morphology, inflammatory response, and microbiota of intra-uterine growth retarded weanling piglets

Table 7 Effects of Bacillus amyloliquefaciens on apoptosis-associated gene expression of weanling piglets with intra-uterine growth retardation

Items^a		NBW-CON (NC group)	IUGR-CON (IC group)	IUGR-BA (IB group)	SEM	Contrast
Items^a		NBW-CON (NC group)	IUGR-CON (IC group)	IUGR-BA (IB group)	SEM	NC vs. IC	IC vs. IB
Jejunum	BCL-2 ^c	1.00	0.53	0.80	0.08	0.033	0.092
	MCL-1 ^b	1.00	0.66	0.85	0.07	0.081	0.402
	BAX ^b	1.00	1.61	1.27	0.13	0.123	0.491
	PLSCR3 ^b	1.00	1.08	1.03	0.14	0.969	0.988
Ileum	BCL-2 ^b	1.00	0.53	0.89	0.08	0.017	0.067
	MCL-1 ^b	1.00	0.81	1.01	0.08	0.626	0.606
	BAX ^c	1.00	1.64	1.08	0.11	NS	NS
	PLSCR3 ^b	1.00	0.94	0.86	0.07	0.952	0.890

^aBAX B-cell lymphoma/leukaemia 2-associated X protein, BCL-2 B-cell CLL/lymphoma 2, IUGR-BA piglets with intrauterine growth retardation fed the Bacillus amyloliquefaciens-supplemented diet, IUGR-CON piglets with intrauterine growth retardation fed the control diet, NBW-CON piglets with normal birth weight fed the control diet, NS nonsignificant values after Kruskal–Wallis comparison test, MCL-1 myeloid cell leukemia 1, PLSCR3 phospholipid scramblase 3
^bOne-way ANOVA test. A value of P < 0.05 was considered as statistically significant
^cNon-parametric Kruskal-Wallis test. A value of P < 0.05 was considered as statistically significant

ISSN: 2049-1891